Stamford, CT -- (SBWIRE) -- 01/27/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Rite Aid Corporation (NYSE:RAD), Tranzbyte Corp (OTCMKTS:ERBB), Hemispherx BioPharma, Inc (NYSEMKT:HEB), J.C. Penney Company, Inc. (NYSE:JCP).
Rite Aid Corporation (NYSE:RAD) opened its last trade at the price of $5.66. Its closing price was $5.47 after losing -4.37% for the day. The company traded with the total volume of 27.83 million shares, while its average trading volume remained 27.02 million shares. The beta of this stock stands at 2.38. Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Has RAD Found The Bottom and Ready To Move Up? Find Out Here
Tranzbyte Corp (OTCMKTS:ERBB) percentage change surged 0.87% to close at $0.0116 with the total traded volume of 672.54 million shares, along with average volume of 151.53 million shares. The 52 week range of the stock remained $0.00 - $0.02, while its day lowest price was $0.01. The share price hit the day highest price of $0.02. Tranzbyte Corporation operates medical marijuana retail dispensaries under the Altitude Organic Medicine brand name in California, Colorado, and Arizona. The company also produces a portfolio of RFID readers, tags, sensor tags, sensor probes, and RFID-enabled data logging tags.
Will ERBB Continue To Move Higher? Find Out Here
Hemispherx BioPharma, Inc (NYSEMKT:HEB) traded on volume of 8.44 million shares in the last session against average volume of 4.43 million shares. The company started its trading session with the price of $0.53 and closed at $0.510 by scoring -7.27%. Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
Why Should Investors Buy HEB After the Recent Fall? Just Go Here and Find Out
J.C. Penney Company, Inc. (NYSE:JCP) started its last trading session with the price of $6.77 and closed at $6.70 by scoring -2.05%. The stock traded with total volume of 17.10 million shares, while the average trading volume remained 25.78 million shares. The beta value of this stock stands at 1.77. Day range for the stock was $6.60 - $6.79. J. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., operates department stores. It sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings.
Will JCP Get Buyers Even After The Recent Rally? Find Out Here
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)